Literature DB >> 3312856

Natural history of candidates for balloon aortic valvuloplasty.

J H O'Keefe1, R E Vlietstra, K R Bailey, D R Holmes.   

Abstract

Recently, balloon aortic valvuloplasty has been proposed for the treatment of severe aortic stenosis in elderly patients when aortic valve replacement has been declined or deferred. The natural history of these patients has not been clearly defined. Therefore, to develop a comparison cohort of patients with unoperated aortic stenosis, we reviewed the records of all Mayo Clinic patients in whom severe aortic stenosis had been diagnosed during the period 1978 through 1985 but no surgical procedure had been performed because the patient declined or the physician deferred this option. Among the 50 patients identified (36 men and 14 women; mean age 77 years, range 60 to 89 years), an operation was declined by 28 and deferred in 22. The diagnosis of aortic stenosis was established clinically by a cardiologist in all 50 patients and independently confirmed by echocardiography, Doppler ultrasonography, or catheterization in 47 of the 50. All patients were symptomatic. Follow-up was complete to September 1986 or death in all 50 patients. Actuarial survival at 1, 2, and 3 years was 57, 37, and 25%, respectively. Survival of age- and sex-matched control subjects was 93, 85, and 77%, respectively (P less than 0.0001 at each 1-year interval). At last follow-up, only 13 of the 50 patients (26%) were alive. A cardiac cause was cited for 36 of the 37 deaths. Because of the poor survival in this group of patients, evaluation of alternative nonsurgical therapeutic modalities such as balloon valvuloplasty is imperative when operative intervention is declined or deferred in elderly patients.

Entities:  

Mesh:

Year:  1987        PMID: 3312856     DOI: 10.1016/s0025-6196(12)65068-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  22 in total

1.  To operate or not on elderly patients with aortic stenosis: the decision and its consequences.

Authors:  B J Bouma; R B van Den Brink; J H van Der Meulen; H A Verheul; E C Cheriex; H P Hamer; E Dekker; K I Lie; J G Tijssen
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 2.  Cardiac valve surgery in the octogenarian.

Authors:  R Prêtre; M I Turina
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 3.  Which strategy for a protein crystallization project?

Authors:  C E Kundrot
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 4.  Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature.

Authors:  L Figulla; A Neumann; H R Figulla; P Kahlert; R Erbel; T Neumann
Journal:  Clin Res Cardiol       Date:  2010-12-17       Impact factor: 5.460

5.  Aortic and mitral valve replacement in an 83-year-old female. 3 years follow-up of 16 mm bileaflet valve at the aortic position.

Authors:  K Tanemoto; M Kuinose; Y Kanaoka; T Murakami; K Kuroki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

6.  [Transcatheter aortic-valve implantation for aortic stenosis. An established procedure?].

Authors:  H R Figulla; M Ferrari
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

Review 7.  Balloon dilatation of the aortic valve in adults: a physician's view.

Authors:  K J Beatt
Journal:  Br Heart J       Date:  1990-04

Review 8.  Percutaneous balloon valve dilatation.

Authors:  M J Levine; R G McKay
Journal:  BMJ       Date:  1989-03-11

9.  Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly.

Authors:  Stefan Sack; Philipp Kahlert; Sasan Khandanpour; Christoph Naber; Sebastian Philipp; Stefan Möhlenkamp; Burkhard Sievers; Hagen Kälsch; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2008-04-03       Impact factor: 5.460

Review 10.  [Decompensated valve failure: the revival of balloon valvuloplasty - percutaneous valve intervention].

Authors:  Stefan Sack; Jochen Menne; Thomas Krüger; Michael Weber; Dieter Müller; Werner Zwehl
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.